CEO
Leverkusen - Bayer is donating medicines and additional financial aid worth a total of approximately
"We want to help people in the affected regions quickly and effectively," said
The donated medicines - Avelox® (antibiotic), Redoxon® (vitamin C), Saridon® (antipyretic/analgesic), and Gadovist® and Ultravist® (contrast media) - have a total value of
Medical and monetary donations to help people in need are an integral part of Bayer's corporate philosophy and commitment to social engagement.
About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2018, the Group employed around 117,000 people and had sales of
Find more information at www.bayer.com.
Follow us on Twitter: twitter.com/BayerPresse_DE
Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
.
(C) 2020 M2 COMMUNICATIONS, source